Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dynamics of actomyosin filaments in the contractile ring revealed by ultrastructural analysis.

Genes to cells : devoted to molecular & cellular mechanisms·2023
Same author

Synthetic augmentation of bilirubin metabolism in human pluripotent stem cell-derived liver organoids.

Stem cell reports·2023
Same author

iPSC-derived type IV collagen α5-expressing kidney organoids model Alport syndrome.

Communications biology·2023
Same author

Engraftment of allogeneic iPS cell-derived cartilage organoid in a primate model of articular cartilage defect.

Nature communications·2023
Same author

B1 SINE-binding ZFP266 impedes mouse iPSC generation through suppression of chromatin opening mediated by reprogramming factors.

Nature communications·2023
Same author

Generation of human induced pluripotent stem cells (CHULAi001-A) from peripheral blood mononuclear cells of a glucose-6-phosphate dehydrogenase (G6PD) deficient subject carrying the Viangchan mutation.

Stem cell research·2022

Related Experiment Video

Updated: May 24, 2026

Generating iPS Cells from MEFS through Forced Expression of Sox-2, Oct-4, c-Myc, and Klf4
13:02

Generating iPS Cells from MEFS through Forced Expression of Sox-2, Oct-4, c-Myc, and Klf4

Published on: April 7, 2008

Methods for iPS cell generation for basic research and clinical applications.

Yuji Mochiduki1, Keisuke Okita

  • 1Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.

Biotechnology Journal
|March 2, 2012
PubMed
Summary
This summary is machine-generated.

Induced pluripotent stem (iPS) cells offer potential for regenerative medicine and drug discovery. Recent advancements have improved iPS cell generation, overcoming previous limitations for clinical applications.

More Related Videos

Generation of Human Cardiomyocytes: A Differentiation Protocol from Feeder-free Human Induced Pluripotent Stem Cells
13:18

Generation of Human Cardiomyocytes: A Differentiation Protocol from Feeder-free Human Induced Pluripotent Stem Cells

Published on: June 28, 2013

Efficient iPS Cell Generation from Blood Using Episomes and HDAC Inhibitors
08:14

Efficient iPS Cell Generation from Blood Using Episomes and HDAC Inhibitors

Published on: October 28, 2014

Related Experiment Videos

Last Updated: May 24, 2026

Generating iPS Cells from MEFS through Forced Expression of Sox-2, Oct-4, c-Myc, and Klf4
13:02

Generating iPS Cells from MEFS through Forced Expression of Sox-2, Oct-4, c-Myc, and Klf4

Published on: April 7, 2008

Generation of Human Cardiomyocytes: A Differentiation Protocol from Feeder-free Human Induced Pluripotent Stem Cells
13:18

Generation of Human Cardiomyocytes: A Differentiation Protocol from Feeder-free Human Induced Pluripotent Stem Cells

Published on: June 28, 2013

Efficient iPS Cell Generation from Blood Using Episomes and HDAC Inhibitors
08:14

Efficient iPS Cell Generation from Blood Using Episomes and HDAC Inhibitors

Published on: October 28, 2014

Area of Science:

  • Biotechnology
  • Stem Cell Biology
  • Regenerative Medicine

Background:

  • Somatic cells can be reprogrammed into induced pluripotent stem (iPS) cells, which share properties with embryonic stem (ES) cells.
  • iPS cells hold promise for patient-specific therapies and drug discovery.
  • Early iPS cell generation methods presented challenges for clinical translation.

Purpose of the Study:

  • To review current advancements in iPS cell generation techniques.
  • To highlight improvements addressing previous limitations in iPS cell production.
  • To discuss future challenges and opportunities in the field of iPS cell research.

Main Methods:

  • Review of recent scientific literature on iPS cell generation.
  • Focus on improved methodologies for reprogramming somatic cells.
  • Analysis of iPS cell characteristics and their implications.

Main Results:

  • Significant improvements in iPS cell generation efficiency and safety have been achieved.
  • New methods have overcome key obstacles to clinical application of iPS cells.
  • Enhanced understanding of iPS cell properties and behavior.

Conclusions:

  • iPS cell technology has advanced considerably, making it more viable for therapeutic use.
  • Continued research is crucial to fully realize the potential of iPS cells in medicine.
  • Future efforts should focus on standardization, safety, and scalability of iPS cell therapies.